| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/29/2009 | US20090028818 Heterocyclic antiviral compounds |
| 01/29/2009 | US20090028814 High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 01/29/2009 | US20090028794 Uses and compositions for treatment of psoriatic arthritis |
| 01/29/2009 | US20090028793 Vascular Tumor Markers |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | CA2720570A1 Methods and compositions for live attenuated viruses |
| 01/29/2009 | CA2697159A1 Antibodies to cd200 and uses thereof in inhibiting immune responses |
| 01/29/2009 | CA2694466A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | CA2694457A1 Compositions and methods for generating an immune response in a subject |
| 01/29/2009 | CA2694397A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv) and use thereof |
| 01/29/2009 | CA2694396A1 Targeted binding agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | CA2694083A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | CA2694001A1 Complexes of grp94 with human immunoglobulin g |
| 01/29/2009 | CA2693503A1 Il-18 receptor antigen binding proteins |
| 01/29/2009 | CA2693305A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 01/29/2009 | CA2693239A1 Inactivated staphylococcal whole-cell vaccine |
| 01/29/2009 | CA2692161A1 Stabilized immune modulatory rna (simra) compounds |
| 01/29/2009 | CA2692006A1 Materials and methods for sperm sex selection |
| 01/29/2009 | CA2691539A1 Modified toxins |
| 01/29/2009 | CA2691218A1 An antigen associated with lung cancers and lymphomas |
| 01/28/2009 | EP2019141A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019140A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2018873A1 Prophylactic/therapeutic agent for cancer |
| 01/28/2009 | EP2018871A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 01/28/2009 | EP2018858A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
| 01/28/2009 | EP2018184A2 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
| 01/28/2009 | EP2018183A2 Lyophilized therapeutic peptibody formulations |
| 01/28/2009 | EP2018182A1 Immunogenic compositions |
| 01/28/2009 | EP2018181A2 Method of vaccinating subjects receiving immune modulating therapy |
| 01/28/2009 | EP2018179A1 Use of antagonists of cxcl13 or cxcr5 for treating wounds or fibrotic diseases |
| 01/28/2009 | EP1725580B1 Isosteric transformation |
| 01/28/2009 | EP1372716B1 Blood cell production via activation of cd163 |
| 01/28/2009 | EP1121135B1 Compositions of beta-glucans and specific immunoglobulins |
| 01/28/2009 | EP1015035B1 Vaccination by topical application of genetic vectors |
| 01/28/2009 | CN101356436A Treatment and diagnosis of obligate intracellular pathogens |
| 01/28/2009 | CN101356195A Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1 |
| 01/28/2009 | CN101355967A Treating inflammatory disorders with antibodies to the alpha-7 |
| 01/28/2009 | CN101355966A Bispecific single chain Fv antibody molecules and methods of use thereof |
| 01/28/2009 | CN101355965A Methods and compositions for the treatment of persistent infections and cancers by inhibiting the programmed cell death 1 (PD-1) phthway |
| 01/28/2009 | CN101355964A Immunoadjuvant |
| 01/28/2009 | CN101355963A Marked bovine viral diarrhea virus vaccines |
| 01/28/2009 | CN101355962A Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| 01/28/2009 | CN101355961A Preparation of vaccine master cell lines using recombinant plant suspension cultures |
| 01/28/2009 | CN101355960A Mucosal and systemic immunizations with alphavirus replicon particles |
| 01/28/2009 | CN101355936A Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic |
| 01/28/2009 | CN101354397A Strategy for retroviral immunotherapy |
| 01/28/2009 | CN101353670A Infectious bovine rhinotracheitis virus recombinant strain, construction method and use thereof |
| 01/28/2009 | CN101353663A Anti-I type diabetes fuse protein and preparation thereof |
| 01/28/2009 | CN101353381A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 01/28/2009 | CN101353375A Method for producing influenza hemagglutinin multivalent vaccine |
| 01/28/2009 | CN101353374A Pronucleus expressed hepatitis a virus recombinant antigen |
| 01/28/2009 | CN101353373A Synthetic peptide vaccines for foot-and-mouth disease |
| 01/28/2009 | CN101353371A H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 01/28/2009 | CN101352571A Medicament for treating encephalitis b and preparation method thereof |
| 01/28/2009 | CN101352570A Diploid cell rabies vaccine and method for preparing purified rabies vaccine |
| 01/28/2009 | CN101352569A Diploid somatic cell encephalitis B vaccine and method for preparing purified encephalitis B vaccine |
| 01/28/2009 | CN100455600C Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 01/28/2009 | CN100455598C Antibody of anti human CD20 from human resources functionally, and application |
| 01/28/2009 | CN100455596C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/28/2009 | CN100455328C Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/28/2009 | CN100455290C Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 01/28/2009 | CN100455275C Medical device with coating that promotes endothelial cell adherence and differentiation |
| 01/27/2009 | US7482441 Artificial chromosomes comprising EHV sequences |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482435 Immunoglobulin for use in human therapeutics and diagnostics |
| 01/27/2009 | US7482434 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 01/27/2009 | US7482430 Modified tumor necrosis factor receptor for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 01/27/2009 | US7482329 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482324 Bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 01/27/2009 | US7482320 Modulation of smooth muscle cell proliferation |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482020 for making an adjuvanted vaccine comprising host albumin. The process comprises mixing host serum or host serum with an antigen, and then mixing the resulting mixture with an adjuvant. |
| 01/27/2009 | US7482017 isolated attenuated flaviviruses , such as West Nile viruses, having modifications that provide phenotypic varation, particularly in comparison to a more virulent reference strains. The invention encompasses the isolated viruses and immunogenic compositions thereof, in addition methods to produce same |
| 01/27/2009 | US7482016 Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides |
| 01/27/2009 | US7482015 Optimized expression of HPV 45 L1 in yeast |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482010 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 01/27/2009 | US7482009 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
| 01/27/2009 | US7482008 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 01/27/2009 | US7482007 Methods of inhibiting angiogenesis to treat cancer with alphavbeta3-specific antibodies |
| 01/27/2009 | US7482006 Culturing yeasts, host cells; biosynthesis |
| 01/27/2009 | US7482005 Methods of treating diseases with anti-VEGF antibodies |
| 01/27/2009 | US7482004 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482002 Method of administering and using VEGF inhibitors for the treatment of prostate cancer |
| 01/27/2009 | US7482001 Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | US7481999 Compounds and methods for modulating OB-cadherin-mediated function |
| 01/27/2009 | US7481998 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 01/27/2009 | US7481997 Snow mountain virus genome sequence, virus-like particles and methods of use |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2380783C Human monoclonal antibodies to prostate specific membrane antigen |
| 01/27/2009 | CA2285040C Death domain containing receptor 5 |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009012493A2 H-antigen binding polypeptides and methods of use |
| 01/22/2009 | WO2009012487A2 Chimeric varicella zoster virus-virus like particles |